Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 59 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Slowly resolving global myocardial inflammation/oedema in Tako-Tsubo cardiomyopathy: evidence from T2-weighted cardiac MRINeil, C.; Nguyen, T.; Kucia, A.; Crouch, B.; Sverdlov, A.; Chirkov, Y.; Mahadevan, G.; Selvanayagam, J.; Dawson, D.; Beltrame, J.; Zeitz, C.; Unger, S.; Redpath, T.; Frenneaux, M.; Horowitz, J.
2012Heart failure, ventricular dysfunction and risk factor prevalence in Australian Aboriginal peoples: the heart of the heart studyMcGrady, M.; Krum, H.; Carrington, M.; Stewart, S.; Zeitz, C.; Lee, G.; Marwick, T.; Haluska, B.; Brown, A.
2012Have mental health education programs influenced the mental health literacy of those with major depression and suicidal ideation?: a comparison between 1998 and 2008 in South AustraliaChamberlain, P.; Goldney, R.; Taylor, A.; Eckert, K.
2012Functional neuroimaging demonstrates that ghrelin inhibits the central nervous system response to ingested lipidJones, R.; McKie, S.; Astbury, N.; Little, T.; Tivey, S.; Lassman, D.; McLaughlin, J.; Luckman, S.; Williams, S.; Dockray, G.; Thompson, D.
2012Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosisNgian, G.; Sahhar, J.; Proudman, S.; Stevens, W.; Wicks, I.; Van Doornum, S.
2012Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculatureKazenwadel, J.; Secker, G.; Liu, Y.; Rosenfeld, J.; Wildin, R.; Cuellar-Rodriguez, J.; Hsu, A.; Dyack, S.; Fernandez, C.; Chong, C.; Babic, M.; Bardy, P.; Shimamura, A.; Zhang, M.; Walsh, T.; Holland, S.; Hickstein, D.; Horwitz, M.; Hahn, C.; Scott, H.; et al.
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancerWeickhardt, A.; Price, T.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A.; Mariadason, J.; Tebbutt, N.
2012The health and cost implications of high body mass index in Australian defence force personnelPeake, J.; Gargett, S.; Waller, M.; McLaughlin, R.; Cosgrove, T.; Wittert, G.; Nasveld, P.; Warfe, P.
2012Abdominal adiposity and obstructive airway disease: testing insulin resistance and sleep disordered breathing mechanismsHaren, M.; Misan, G.; Paterson, T.; Ruffin, R.; Grant, J.; Buckley, J.; Howe, P.; Newbury, J.; Taylor, A.; McDermott, R.
2012Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemiaTasian, S.; Doral, M.; Borowitz, M.; Wood, B.; Chen, I.-M.; Harvey, R.; Gastier-Foster, J.; Willman, C.; Hunger, S.; Mullighan, C.; Loh, M.